Epack Prefab Technologies Files Q3FY26 Monitoring Agency Report with CARE Ratings
Epack Prefab Technologies Limited filed its Q3FY26 monitoring agency report showing Rs. 102.48 crore utilization from its Rs. 300 crore IPO proceeds. CARE Ratings noted fund comingling issues as Rs. 11.72 crore was used from current accounts. The company completed its debt repayment objective of Rs. 70.00 crore and made progress on manufacturing expansion projects. Unutilized proceeds of Rs. 197.52 crore are invested in fixed deposits across multiple banks with interest rates ranging from 6.15% to 6.75%.

*this image is generated using AI for illustrative purposes only.
Epack Prefab Technologies Limited has filed its quarterly monitoring agency report for Q3FY26 with stock exchanges, covering the utilization of proceeds from its Rs. 300 crore initial public offering. The report, prepared by CARE Ratings Limited and dated February 11, 2026, provides detailed insights into how the company deployed IPO funds during the quarter ended December 31, 2025.
IPO Proceeds Utilization Overview
During Q3FY26, Epack Prefab Technologies utilized Rs. 102.48 crore from its IPO proceeds across multiple objectives. However, CARE Ratings noted a significant operational issue regarding fund management. The monitoring agency observed that Rs. 11.72 crore was utilized from the company's current account rather than designated IPO proceeds accounts, resulting in fund comingling.
| Parameter | Details |
|---|---|
| Total IPO Size | Rs. 300 crore |
| Q3FY26 Utilization | Rs. 102.48 crore |
| Fund Comingling | Rs. 11.72 crore from current account |
| Unutilized Amount | Rs. 197.52 crore |
Objective-wise Fund Deployment
The company's IPO proceeds were allocated across five primary objectives, with varying levels of utilization during the quarter:
Manufacturing Expansion Projects: The company made progress on two key manufacturing initiatives. For the expansion of existing manufacturing facility at Mambattu (Unit 4) in Andhra Pradesh, Rs. 23.89 crore was utilized during Q3FY26, with Rs. 14.76 crore from the monitoring account and Rs. 9.13 crore from current account. The original allocation for this project was Rs. 58.17 crore.
Debt Repayment: The company completed the full repayment objective during Q3FY26, utilizing the entire allocated Rs. 70.00 crore for repayment and prepayment of certain borrowings.
Share Issue Expenses: Rs. 8.59 crore was utilized towards share issue expenses from the original allocation of Rs. 14.82 crore. This utilization came from multiple sources: Rs. 2.54 crore from allotment account, Rs. 4.51 crore from monitoring account, and Rs. 1.54 crore from current account.
Investment of Unutilized Proceeds
The company has invested its unutilized IPO proceeds of Rs. 197.52 crore primarily in fixed deposits across multiple banks:
| Bank | Amount (Rs. Crore) | Maturity Date | Interest Rate |
|---|---|---|---|
| YES Bank Ltd | 50.00 | 03-10-2026 | 6.60% |
| Indusind Bank Ltd | 50.00 | 03-10-2026 | 6.75% |
| AXIS Bank Ltd | 25.00 | 03-10-2026 | 6.15% |
| ICICI Bank Ltd | 24.60 | 03-10-2026 | 6.25% |
| ICICI Bank Ltd | 24.50 | 08-10-2026 | 6.25% |
Monitoring Agency Observations
CARE Ratings highlighted that the fund comingling restricted their ability to directly verify and ascertain utilizations, as IPO proceeds were mixed with other cash flows. The monitoring agency relied on management certificates and CA certificates dated February 6, 2026, from Talati And Talati LLP for verification of Q3FY26 utilizations.
The report confirmed no deviation from stated objectives, with the range of deviation marked as not applicable. All utilizations were deemed consistent with disclosures in the offer document, and no material deviations requiring shareholder approval were identified.
Project Timeline Status
Most objectives remain on track with their March 31, 2026 completion timeline. The new manufacturing facility at Ghiloth Industrial Area and the Mambattu expansion project are both ongoing as per schedule. The debt repayment objective has been completed, while general corporate purposes and share issue expenses continue as planned with no reported delays.

































